Clinical Trial Update: Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Clinical trial update indicates that the Phase 3 efficacy study of Dimethyl Fumarate for moderate-to-severe plaque psoriasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Forward-Pharma GmbH | Conditions: Plaque Psoriasis | Phase 3 | Status: WITHDRAWN